GVS-24527-25928
4 vaccinations
7 coded responses
46 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-15
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-01-28
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams — Feeling: GoodFree text: Vivid dreamsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Nose bleed yesterday and also occurred 3 and 4 days after the first vaccine but I thought it was a coincidence thenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
- 2021-07-29
-
2021-11-17
Dose 3 — Pfizer-BioNTech
- 2021-11-17
-
2021-11-18
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: Mild chest pain-lasted about 20 minutesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-24
- 2021-12-01
- 2021-12-10
- 2021-12-15
- 2021-12-22
- 2021-12-29
-
2022-10-12
Dose 4 — Pfizer-BioNTech
-
2022-10-12
Health check-in — day 0, dose 4Feeling: Fair · Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Nausea, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-10-16
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Palpitations — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Likely unrelated, but heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — days 1–6 daily, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-18
- 2022-10-18
- 2022-10-19
- 2022-10-26
- 2022-11-02
-
2022-11-16
Survey response — day 35, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Currently have a coldMedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Survey response — day 42, dose 4MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose, nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2023-01-11
Survey response — 3 months, dose 4MedDRA: Cough, Fatigue, Nasal congestion, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-11
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-12
- 2023-01-12
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Vivid dreams
Systemic reaction (other): Nose bleed yesterday and also occurred 3 and 4 days after the first vaccine but I thought it was a coincidence then
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Mild chest pain-lasted about 20 minutes
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Likely unrelated, but heart palpitations
Release 12 — day 35, dose 4
Symptoms: Currently have a cold
Release 12 — day 42, dose 4
Symptoms: Runny nose, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Abnormal dreams | ✓ | ✓ | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
| SRO | Palpitations | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release